Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / January 10, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: PGT Innovations, Inc. (NYSE:PGTI)'s ...
2024-01-08 14:41:28 ET More on Bristol-Myers Squibb Company Bristol-Myers Squibb Company (BMY) J.P. Morgan 42nd Annual Healthcare Conference (Transcript) Bristol-Myers Squibb Company (BMY) Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript) Bristol-My...
NEW YORK, NY / ACCESSWIRE / January 8, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: RayzeBio, Inc. (NASDAQ:RYZB)'s sale ...
NEW YORK, NY / ACCESSWIRE / January 4, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: RayzeBio, Inc. (NASDAQ:RYZB)'s sale ...
2024-01-03 17:17:52 ET Summary Bristol-Myers Squibb Company experienced a poor year in terms of share price performance in 2023, with a 27% decline in value. Bristol-Myers has focused on its late-stage pipeline and made several recent acquisitions geared towards offsetting losses ...
2024-01-03 07:53:17 ET More on Bristol-Myers Squibb Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Bristol Myers Squibb: Too Many Headwinds To Ignore, Despite The Stellar Management Bristol Myers Squibb: Aggressive M&A, A Riskier Strat...
2024-01-03 07:00:00 ET Summary The biotech industry experienced a challenging year in 2023 due to a rising 10-year Treasury yield. In 2024, the 10-year yield should favorably support biotech stocks. Promising advancements in weight loss drugs, neuroscience, oncology, and gene ...
2024-01-01 15:37:15 ET More on AbbVie, Bristol-Myers Squibb Company , etc. Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Bristol Myers Squibb: Too Many Headwinds To Ignore, Despite The Stellar Management Bristol Myers Squibb: Aggress...
2023-12-31 02:49:47 ET Summary Bristol-Myers Squibb is a well-known blue-chip stock with a dividend yield exceeding 4.6%. Since 2019, Bristol-Myers Squibb has acquired pharmaceutical companies worth more than $115 billion, allowing it to expand its drug portfolio and product candi...
2023-12-28 08:15:02 ET Canaccord Genuity analyst issues BUY recommendation for KRTX on December 28, 2023 08:35AM ET. The previous analyst recommendation was Buy. KRTX was trading at $317.16 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
News, Short Squeeze, Breakout and More Instantly...
Karuna Therapeutics Inc. Company Name:
KRTX Stock Symbol:
NYSE Market:
Karuna Therapeutics Inc. Website:
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) fell 51.9% to $0.1549 on volume of 312,863,578 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 5.4% to $3.51 on volume of 229,852,079 shares SoundHound AI Inc. (SOUN) fell 3.2% to $8.37 on volu...
A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) fell 48.9% to $0.1647 on volume of 56,261,089 shares SoundHound AI Inc. (SOUN) rose 5.2% to $9.1021 on volume of 55,444,995 shares Presto Automation Inc. (PRST) rose 93.4% to $0.435 on volume of 51,103,745 sh...